Try it
PSM · Leprosy: lepra reactions
Sample itemA 35-year-old man with borderline tuberculoid leprosy has been on multidrug therapy for 3 months. He now has erythema and swelling of his existing skin patches and a tender, thickened ulnar nerve with new weakness of finger abduction. He has no fever or new skin nodules. What is the most appropriate management?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Continue multidrug therapy and start oral corticosteroids
Inflammation of existing lesions with neuritis in borderline disease is a type 1 (reversal) reaction, a delayed hypersensitivity response during treatment. Nerve function impairment is an indication for prompt corticosteroids to prevent permanent deficit, while the antileprosy drugs are continued. Thalidomide is used in erythema nodosum leprosum (type 2 reaction) and is teratogenic.
Option by option
A. Stop multidrug therapy until the reaction settles
Stopping the antibacterial drugs is not needed as the reaction is immunological and not drug-related.
B. Continue multidrug therapy and start oral corticosteroids (correct)
A type 1 reaction with nerve involvement needs steroids while multidrug therapy continues.
C. Replace multidrug therapy with a second-line regimen for drug resistance
The picture is an immune reaction to dying bacilli and not evidence of drug resistance.
D. Stop multidrug therapy and start thalidomide
Thalidomide treats type 2 reactions with painful nodules and systemic upset, not this picture.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More PSM questions
- BiostatisticsOf 200 people who truly have a disease, a screening test is positive in 180. What is the…
- Environmental healthAfter one hour of contact time, what residual free chlorine level is generally recommend…
- EpidemiologyWhich study design is the most efficient for investigating risk factors of a rare disease?
- BiostatisticsIn hypothesis testing, a Type I error is: